EuroQol is pleased to announce that its Version Management Committee has recently approved 30 language versions of the Interviewer Administered (IA) Proxy 1 EQ-5D variant. The Proxy 1 IA version is available in 28 languages for EQ-5D-5L and in English…
The research team for the new EQ-5D-5L valuation study for the United Kingdom has been finalised. This team will bring significant experience and expertise to the valuation study. They were carefully selected by the project’s Steering Group and come from…
A review identifying which multi-attribute utility instruments (MAUIs) are recommended for use in official national pharmacoeconomic (PE) guidelines has been published in the European Journal of Health Economics. The study reviewed PE guidelines where health technology assessment is used to…
In light of the Covid-19 crisis emerging worldwide, we kindly inform you that the deadline for submitting abstracts for the 37th EuroQol Plenary Meeting on 16-19 September 2020 in Chicago is postponed to Monday 11 May 2020, 23.59 CET. Please…
EuroQol is pleased to launch a new whiteboard animation, ‘How to obtain EQ-5D’. The animation is intended for anyone interested in using EQ-5D. It describes the process of registering and gaining access to the instrument, one of the most widely…
The 9th Joint Call for Proposals by the EQ Working Groups is now open! The EuroQol Research Foundation is inviting applications for funding by its competitive research funding programs. Through this program, the Foundation aims to serve the public interest…
EuroQol is pleased to launch the Chinese (Mandarin), Japanese and Spanish version of the whiteboard animation ‘Explaining the EQ-5D in about two-and-a-half-minutes’. The animation is intended for anyone interested in EQ-5D, one of the most widely used measures of patient…
NICE has announced on their website today their decision to support the development of a new EQ-5D-5L valuation study for England. The new study will be funded and managed by the EuroQol Group, with ongoing advisory input from NICE, the…
EuroQol has developed a summary slide kit providing a summary of the EuroQol Group, the EQ-5D measure, use of EQ-5D, availability of value sets and translations, information on how to obtain EQ-5D for use in a study, and an overview…
EuroQol is pleased to launch a whiteboard animation ‘Explaining the EQ-5D in about two-and-a-half-minutes’. The animation is intended for anyone interested in EQ-5D, one of the most widely used measures of patient reported outcomes. It describes the instrument’s characteristics and…